Gelonghui July 14th 丨Unknown Pharmaceutical (002581.SZ) announced its 2023 semi-annual results forecast. Net profit and loss attributable to shareholders of listed companies for the reporting period was 47,649 million yuan, a year-on-year profit to loss; net profit loss of 42.0339 million yuan after deducting non-recurring profit and loss; and a basic loss of 0.0722 yuan/share in earnings per share. The reason for the decline in the company's performance during the reporting period was a decrease in the company's investment income.
未名医药(002581.SZ)：上半年预亏4764.90万元 同比盈转亏
Unknown Pharmaceuticals (002581.SZ): Advance loss of 47.649 million yuan in the first half of the year, year-on-year profit and loss
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.